Factors that influence adherence with disease-modifying therapy in multiple sclerosis

被引:0
|
作者
Treadaway, KD
Brannon, KD
Morrison, A
Remington, GM
Olek, M
Racke, MK
Frohman, EM
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A30 / A30
页数:1
相关论文
共 50 条
  • [1] Factors that influence adherence with disease-modifying therapy in multiple sclerosis
    Treadaway, K
    Hawker, K
    Racke, M
    Brannon, K
    Morrison, A
    Remington, G
    Frohman, E
    Cohen, B
    Corboy, J
    Simsarian, J
    Lynch, S
    Jeffery, D
    MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [2] A multivariate analysis of factors that influence adherence with disease-modifying therapy in multiple sclerosis
    Treadaway, Katherine
    Cutter, Gary
    Lynch, Sharon G.
    Corboy, John
    Simsarian, James
    Jeffery, Douglas
    Cohen, Bruce
    Mankowski, Ken
    Guarnaccia, Joseph B.
    Schaeffer, Lawrence
    Brandes, David
    Kaufman, Charles
    Duncan, David
    Marder, Ellen
    Allen, Arthur
    Harney, John
    Cooper, Joanna A.
    Woo, Douglas
    Racke, Michael K.
    Stuve, Olaf
    Kanter, Roy
    Frohman, Elliot
    MULTIPLE SCLEROSIS, 2008, 14 : S182 - S182
  • [3] Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis
    von Gaudecker, Jane R.
    JOURNAL OF NEUROSCIENCE NURSING, 2018, 50 (05) : 302 - 302
  • [4] Adherence of Adolescents to Multiple Sclerosis Disease-Modifying Therapy
    Thannhauser, Jennifer E.
    Mah, Jean K.
    Metz, Luanne M.
    PEDIATRIC NEUROLOGY, 2009, 41 (02) : 119 - 123
  • [5] Patient choice and adherence with disease-modifying therapy in multiple sclerosis
    Burke, G
    Pozo, A
    Nairne, A
    Birmingham, H
    Gregory, R
    Palace, JA
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S189 - S189
  • [6] Factors that influence adherence with disease-modifying therapy in MS
    Katherine Treadaway
    Gary Cutter
    Amber Salter
    Sharon Lynch
    James Simsarian
    John Corboy
    Douglas Jeffery
    Bruce Cohen
    Ken Mankowski
    Joseph Guarnaccia
    Lawrence Schaeffer
    Roy Kanter
    David Brandes
    Charles Kaufman
    David Duncan
    Ellen Marder
    Arthur Allen
    John Harney
    Joanna Cooper
    Douglas Woo
    Olaf Stüve
    Michael Racke
    Elliot M. Frohman
    Journal of Neurology, 2009, 256 : 568 - 576
  • [7] Factors that influence adherence with disease-modifying therapy in MS
    Treadaway, Katherine
    Cutter, Gary
    Salter, Amber
    Lynch, Sharon
    Simsarian, James
    Corboy, John
    Jeffery, Douglas
    Cohen, Bruce
    Mankowski, Ken
    Guarnaccia, Joseph
    Schaeffer, Lawrence
    Kanter, Roy
    Brandes, David
    Kaufman, Charles
    Duncan, David
    Marder, Ellen
    Allen, Arthur
    Harney, John
    Cooper, Joanna
    Woo, Douglas
    Stuve, Olaf
    Racke, Michael
    Frohman, Elliot M.
    JOURNAL OF NEUROLOGY, 2009, 256 (04) : 568 - 576
  • [8] Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis
    Schwarz, Carolyn
    Grover, Stephanie
    Powell, Victoria
    Noguera, Austin
    Mah, Jean
    Mar, Soe
    Mednick, Lauren
    Banwell, Brenda
    Alper, Gulay
    Graves, Jennifer
    Lotze, Timothy
    Tillema, Jan-Mendelt
    Rensel, Mary
    Gorman, Mark
    Ness, Jayne
    Waldman, Amy
    Schreiner, Teri
    Waubant, Emmanuelle
    Yeh, E. Ann
    NEUROLOGY, 2017, 88
  • [9] Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis
    Schwartz, Carolyn E.
    Grover, Stephanie A.
    Powell, Victoria E.
    Noguera, Austin
    Mah, Jean K.
    Mar, Soe
    Mednick, Lauren
    Banwell, Brenda L.
    Alper, Gulay
    Rensel, Mary
    Gorman, Mark
    Waldman, Amy
    Schreiner, Teri
    Waubant, Emmanuelle
    Yeh, E. Ann
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : 175 - 185
  • [10] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401